The FDA commissioned a study from the National Academies of Sciences, Engineering, and Medicine (NASEM) on the safety, effectiveness and use of compounded bio-identical hormone therapy (cBHT or cBHRT). The NASEM committee has suggested restricting use of cBHT to patients with allergies to FDA-approved drugs, despite the fact that many FDA-approved therapies may not meet the dosing needs of all patients.

To keep Compounding Pharmacies available to all those who rely on compounding to have access to medications that are unique to the patients specific needs, whether that is specific dosing requirement or allergen free medications, If you are taking or have taken compounded hormone therapy please take the time to share your experiences by providing a testimonial at www.A4PC.org/cbhtandme. The more information we can gather, and the more detailed it is, the better we can support the millions of patients who rely on cBHT.